Clinical Trial Update: FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy [NA]

View source ↗

Summary

Clinical trial evaluating FibroScan in patients with cirrhosis, hepatitis B, or hepatitis C undergoing liver biopsy has completed and posted its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatitis B
• Hepatitis C

Snippet

Sponsor: Afdhal, Nezam, M.D. | Conditions: Cirrhosis, Hepatitis B | NA | Status: COMPLETED | Results posted: 2017-10-27